Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies

266Citations
Citations of this article
390Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The intake of fish and polyunsaturated fatty acids (PUFAs) may benefit cognitive function. However, optimal intake recommendations for protection are unknown. Objective: We systematically investigated associations between fish and PUFA intake and mild-to-severe cognitive impairment risk. Design: Studies that reported risk estimates for mild cognitive impairment (MCI), cognitive decline, dementia, Alzheimer disease (AD), or Parkinson disease (PD) from fish, total PUFAs, total n-3 (v-3) PUFAs, or at least one n-3 PUFA were included. Study characteristics and outcomes were extracted. The pooled RR was estimated with the use of a random-effects model metaanalysis. A dose-response analysis was conducted with the use of the 2-stage generalized least-squares trend program. Results: We included 21 studies (181,580 participants) with 4438 cases identified during follow-up periods (2.1-21 y). A 1-serving/wk increment of dietary fish was associated with lower risks of dementia (RR: 0.95; 95% CI: 0.90, 0.99; P = 0.042, I2 = 63.4%) and AD (RR: 0.93; 95% CI: 0.90, 0.95; P = 0.003, I2 = 74.8%). Pooled RRs of MCI and PD were 0.71 (95% CI: 0.59, 0.82; P = 0.733, I2 = 0%) and 0.90 (95% CI: 0.80, 0.99; P = 0.221, I2 = 33.7%), respectively, for an 8-g/d increment of PUFA intake. As an important source of marine n-3 PUFAs, a 0.1-g/d increment of dietary docosahexaenoic acid (DHA) intake was associated with lower risks of dementia (RR: 0.86; 95% CI: 0.76, 0.96; P < 0.001, I2 = 92.7%) and AD (RR: 0.63; 95% CI: 0.51, 0.76; P < 0.001, I2 = 94.5%). Significant curvilinear relations between fish consumption and risk of AD and between total PUFAs and risk of MCI (both P-nonlinearity < 0.001) were observed. Conclusions: Fishery products are recommended as dietary sources and are associated with lower risk of cognitive impairment. Marinederived DHA was associated with lower risk of dementia and AD but without a linear dose-response relation.

References Powered by Scopus

Measuring inconsistency in meta-analyses

48627Citations
N/AReaders
Get full text

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

18771Citations
N/AReaders
Get full text

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

3378Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention

408Citations
N/AReaders
Get full text

Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases

215Citations
N/AReaders
Get full text

Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss

207Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, Y., Chen, J., Qiu, J., Li, Y., Wang, J., & Jiao, J. (2016). Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies. American Journal of Clinical Nutrition, 103(2), 330–340. https://doi.org/10.3945/ajcn.115.124081

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 106

59%

Researcher 42

23%

Professor / Associate Prof. 21

12%

Lecturer / Post doc 10

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 74

42%

Nursing and Health Professions 43

24%

Agricultural and Biological Sciences 37

21%

Biochemistry, Genetics and Molecular Bi... 23

13%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 2

Save time finding and organizing research with Mendeley

Sign up for free